Skip to main content
Medical information Clinical review pending

Transplant Testing

HLA Pretransplant Workup Sensitized Recipient Panel 5 Test

This test evaluates compatibility for organ transplants in patients who have previously developed antibodies (sensitized recipients). It helps identify the best donor matches to minimize rejection risk.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube). Confirm specific volume requirements with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for the patient. However, if the patient is on dialysis, specimens should ideally be collected 48 hours after the dialysis session. A doctor's prescription on letterhead is mandatory. Include one photograph each of the recipient and potential donor, duly stamped. A signed Consent form for HLA Typing for Solid Organ Transplant (Form 33) is required.
Test priceKSh 90,090

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA Pretransplant Workup Sensitized Recipient Panel 5 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients awaiting kidney or liver transplantation.
  • ✓Individuals with a history of previous organ transplants.
  • ✓Patients who have received blood transfusions.
  • ✓Patients with a history of multiple pregnancies.
  • ✓Individuals with known or suspected sensitization to HLA antigens.
  • ✓Patients with chronic kidney disease or liver disease requiring transplantation.
02

In plain language

What this test helps you understand

This test is used to determine the compatibility between a sensitized organ transplant recipient and potential donors. It helps identify the best possible matches, reducing the risk of transplant rejection and improving the chances of a successful transplant outcome.
The HLA Pretransplant Workup Sensitized Recipient Panel 5 Test is a crucial assessment for individuals awaiting organ transplantation who have become sensitized. Sensitization means the patient has developed antibodies against HLA (Human Leukocyte Antigen) markers, which can make finding a compatible donor more challenging and increase the risk of transplant rejection. This comprehensive test panel helps identify potential donors with the lowest risk of triggering a rejection response. It involves several advanced laboratory techniques to provide a detailed compatibility profile. Understanding this profile is vital for successful transplantation. This test is particularly important for patients with a history of previous transplants, blood transfusions, or pregnancies, as these can lead to sensitization.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for the patient. However, if the patient is on dialysis, specimens should ideally be collected 48 hours after the dialysis session. A doctor's prescription on letterhead is mandatory. Include one photograph each of the recipient and potential donor, duly stamped. A signed Consent form for HLA Typing for Solid Organ Transplant (Form 33) is required.
SampleBlood sample (EDTA tube). Confirm specific volume requirements with the laboratory before booking.
MethodologyThe test panel typically includes: HLA DNA Typing (for Kidney/Liver), PCR Low Resolution Luminex for HLA typing, T & B cell lymphocyte flow cytometry crossmatch against potential donors, and Single antigen bead (SAB) IgG Class I & II Luminex testing.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies pre-existing antibodies and HLA types but cannot predict all potential complications or guarantee transplant success. Results must be interpreted in the context of the patient's overall clinical condition. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A sensitized recipient is someone who has developed antibodies against HLA antigens, often due to previous transplants, blood transfusions, or pregnancies. These antibodies can make finding a compatible donor more difficult.
This test helps identify the best possible donor match for sensitized patients, significantly reducing the risk of the body rejecting the transplanted organ.
A blood sample is required for this test. Please ensure you follow the specimen collection instructions provided by the laboratory.
Confirm with the laboratory before booking.
A doctor's prescription on letterhead, photographs of the recipient and donor (stamped), and a signed Consent form for HLA Typing for Solid Organ Transplant (Form 33) are required.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp